Hoyos Rocio Martininsider trades
In SEC Form 4 filings, Hoyos Rocio Martin is listed as Chief Strategy Officer of Atrium Therapeutics, Inc. (RNA). Hoyos Rocio Martin reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 22.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RNAAtrium Therapeutics, Inc. | Chief Strategy Officer | 1 | Sep 22 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-22
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.